TESARO’s Mary Lynne Hedley and Lonnie Moulder Named EY National Entrepreneurs of the Year®
November 20 2017 - 8:00AM
TESARO, Inc., an oncology-focused biopharmaceutical company, is
proud to announce that co-founders Lonnie Moulder, CEO, and Mary
Lynne Hedley, Ph.D., President and COO, have been named EY
Entrepreneurs of the Year® 2017 Overall National Award Winners.
They were also recognized as the National Award Winners in the Life
Sciences category.
“TESARO could not have achieved this honor
without the dedicated work of our associates and our strategic
partners in advocacy, industry and academia. We are especially
grateful to the patients who selflessly participate in our clinical
programs, and who with their advocates help us to understand the
needs of people living with cancer,” said Dr. Hedley. “We are
humbled to accept this award on behalf of our entire TESARO team
and we congratulate all of the entrepreneurs who participated in
the 2017 national program; their vision and commitment inspire each
of us to dream and accomplish more.”
“Thank you to EY and the judges for recognizing
TESARO and the important work our team of associates does each day
to address the needs of the patients we serve,” said Mr. Moulder.
“We founded TESARO with a commitment to building a
biopharmaceutical company that strives to put the patient at the
center of what we do and because of our passionate and committed
associates we have had the privilege of bringing two important new
medicines to the cancer community in just seven years.”
As TESARO leaders, Mr. Moulder and Dr. Hedley
enable their team to continuously seek out new possibilities to
responsibly develop and commercialize innovative cancer treatments.
Since its founding in 2010, TESARO has become a leading
oncology-focused biopharmaceutical company with more than 750
associates across the U.S. and Europe. With a deep pipeline of new
product candidates, TESARO is well positioned to implement our
mission and deliver additional meaningful cancer therapies to
patients over the next several years.
Earlier this year, Mr. Moulder and Dr. Hedley
were recognized as EY Entrepreneurs of the Year in the Life
Sciences category for the New England region, which qualified them
to be considered for the Entrepreneur of the Year 2017 national
program.
To view the full list of this year’s winners,
please visit:
http://www.ey.com/us/en/about-us/entrepreneurship/entrepreneur-of-the-year.
About EY Entrepreneur of the
Year®EY Entrepreneur of the Year is the world’s most
prestigious business award for entrepreneurs. The unique award
makes a difference through the way it encourages entrepreneurial
activity among those with potential and recognizes the contribution
of people who inspire others with their vision, leadership and
achievement. As the first and only truly global award of its kind,
Entrepreneur of the Year celebrates those who are building and
leading successful, growing and dynamic businesses, recognizing
them through regional, national and global awards programs in more
than 145 cities in more than 60 countries.
About TESAROTESARO is an
oncology-focused biopharmaceutical company devoted to providing
transformative therapies to people bravely facing cancer. For more
information, visit www.tesarobio.com, and follow us on Twitter and
LinkedIn.
Investor/Media Contact:Jennifer
DavisVice President, Corporate Communications & Investor
Relations+1.781.325.1116 or jdavis@tesarobio.com
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Sep 2023 to Sep 2024